63 results about "Obese subjects" patented technology

The invention herein generally relates to pharmaceutical formulations and methods of treating an overweight or obese subject, and overweight- or obesity-related conditions.

A therapeutic bed or treatment table capable of being employed for a massage or rendering chiropractic, medical, therapeutic, or other treatment to a patient or customer includes an upper torso support cushion having a plurality of breast recesses configured for accommodating human breasts; and an abdominal support cushion having an abdominal recess configured for accommodating a mid-section of an obese person or pregnant woman, wherein the plurality of recesses is configured to provide an adjustable support structure adaptive to the size of the human breasts and/or the mid-section of an obese person or pregnant woman. In an alternative embodiment, an unitary torso-abdominal support cushion is provided having a recess configured for accommodating human breasts and accommodating the mid-section of an obese person or pregnant woman.

The invention relates to flour suitable for obese patients. The special meal flour for preparing foods for obese patients is prepared in the by uniformly mixing power made of rhizoma polygonati, semencassiae, gingko, raw hawthorn, tuckahoe, white lablab bean, Chinese yam and semen coicis with whole wheat (with a husk), oat, azuki bean and black bean. The flour can be used for producing various foods suitable for obese patients to eat as a principle food. The flour has the obvious effects of systemically adjusting lipid metabolism and glucose metabolism, losing weight, lowering blood fat, improving microcirculation and eliminating radicals. The special meal flour is suitable for patients with adiposity, adiposis hepatica, hyperlipemia, high blood viscosity, hypertension and diabetes mellitus, and for middle-aged and old people to keep healthy and eat.

The present invention provides fat-binding polymers, which comprise dialkanolamine, dialkanolammonium, aminoalkylpolyol, and ammoniumalkylpolyol pendant groups for subjects in need of fat removal from the gastrointestinal tract, particularly subjects suffering from steatorrhea and/or experiencing side effects from lipase inhibitors. Patients being administered with lipase inhibitors are typically being treated for Type II Diabetes, streatorrhea, and hypertriglyceridemia. The fat binding polymers of this invention are also suitable for use with obese subjects.

The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g., a MetAP-2 inhibitor.

The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor.

The invention relates to an application of Chinese yam polysaccharide in the preparation of a medicament for treating obesity. The Chinese yam polysaccharide is an active ingredient which is extracted and separated from dry rhizomes of Chinese yam, and the extracted and separated Chinese yam polysaccharide and pharmaceutically acceptable carriers or auxiliary ingredients are prepared into a pharmaceutical preparation such as capsules, granules, tablets, pulvis, oral liquid or syrups. A great number of clinical observations and animal experiments show that the Chinese yam polysaccharide has good weight-reducing effect, can be used for curing and improving obesity, effectively reduces the weight of the salad dodger, and is especially applicable to patients with obesity, who also suffer from hyperglycemia, lower immune response and premature senility.

In order to reduce the glycemic load in the daily nutrition of diabetics, obese and for weight-reducing diets, this invention claims cooking or baking processes and other procedures for food—rich in carbohydrates—in which, the structure of the raw complex carbohydrates (amylose, amylopectin, etc.) is mostly preserved and/or short saccharides are encapsulated. This objective is attained by reducing the magnitude of the complex carbohydrate fractioning by the undesired effect of adiabatic heating during grain grinding, or during conventional cooking and also through the encapsulation of already processed monosaccharide's, disaccharides or broken carbohydrate chains in capsules within denaturalized protein matrixes, in order to make their digestion deeper and longer. These processes and procedures allow the ingestion of less restricted portions of food, very similar to the conventional ones (bread, rice, potato, pastas) while due to their prolonged digestion, it naturally limits the immediate production of glucose. This type of food is defined as: “Deep Diet” or “Deep Nutrition” (Dieta Profunda in Spanish). These processes and procedures allow preparing food recipes and flavors very similar to those of a conventional nature (bread, rice, potatoes, pasta) while because of their prolonged digestion are able to reduce the immediate production of glucose (Glycemic Index), thus generating healthier conditions for diabetics and obese, appetite satisfaction and reduction of food anxiety.

The invention discloses a fruity soda water with zero heat. The fruity soda water with zero heat mainly comprises, by weight, 0.01-1 part of stevioside, 0.1-10 parts of erythrose alcohol, 0.5-0.8 part of sodium bicarbonate, 0.0005-0.001 part of calcium chloride, 0.0005-0.001 part of magnesium sulfate, 0.0005-0.003 part of sodium sulfate, 0.5-0.8 part of natural perfume, 0.01202-0.166 part of vitamin ingredient and purified water dissolved with carbon dioxide. The fruity soda water with zero heat has simple and easily available raw materials, good mouthfeel and no heat, is suitable for diabetes patient, the obese and the group needing less energy intake, and has good health care function. Materials used in the invention contain no heat, provide a product with diversified taste and supplement everyday vitamin loss in human body; addition of erythritol benefits functions of metabolism and toxin expelling and satisfies diversified mouthfeel demand and pursuit of people for health.

The invention provides a low calorie fruit juice beverage. The beverage has the advantages of simple and easily available raw materials, good taste, utilization of a calorie-free purely natural sweetener, suitability for diabetic patients, obesity subjects and people needing reduced energy intake and a high health care function, and overcomes shortcomings of conventional fruit juice beverages. The low calorie fruit juice beverage in the invention mainly comprises the following raw materials of purified water, condensed fruit juice, stevioside, erythritol, a sour additive and natural perfume; the beverage further comprises a plurality of vitamin components, which supplements vitamins that human bodies lose every day; increased erythritol has the functions of metabolism and toxin expelling; addition of natural perfume of different taste enables people's demand for a plurality of flavor to be satisfied.

Disclosed herein are compositions and methods for lowering Apolipoprotein C-III (ApoC-III) in a subject in need thereof. Subjects in need of ApoC-III reduction include subjects with elevated ApoC-III levels, subjects with a condition associated with ApoC-III, subjects with diabetes, obese subjects and subjects with cardiovascular disease. Compositions to lower ApoC-III include compounds targeting Apolipoprotein B (ApoB) such as Mipomersen and other antisense compound targeting ApoB.

An orally taken Chinese medicine for treating hyperlipemia and obesity is proportionally prepared from 6 Chinese-medicinal materials including rhubarb, tuckahoe, haw, immature bitter orange, etc.

Presented herein is a methodology for reducing weight in obese subjects and in patients receiving various medical treatments that are accompanied with weight gain. The methodology allows for management of weight gain, management of triglyceride levels and weight reduction in obese subjects.

A method of analyzing the likelihood of weight regain in a subject who has reached a target weight by practicing a weight loss program is disclosed. The method comprises determining an amount or presence of at least one microbe and/or product thereof in the gut microbiome of the subject, wherein the amount of the at least one microbe is altered during a prior weight gain period of the subject to reach a level representative of an obese subject and further wherein the amount of the at least one microbe is retained at the level following the weight loss program, wherein the amount or presence of the at least one microbe or product thereof is predictive of weight regain.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for losing weight and facilitating feces excretion. The traditional Chinese medicine composition comprises moringa oleifera. The traditional Chinese medicine composition has the advantages that the traditional Chinese medicine composition is particularly applicable to treating constipation due to dysfunction of spleens in transportation, yin deficiency, fluid exhaustion and intestinal dryness and also can be used treating persons suffering from constipation or obesity due to enduring illness, little activity and slow peristalsis of intestines.

The invention relates to a composition used for slimming and reducing lipid. The invention discloses a new composition formed by lily, galangal, 1-deoxynojirimycin, nuciferine, pagodatree flower buds, kudzu vine root, poria cocos, kelp, lophatherum gracile and functional oligosaccharide, calcium pyruvate and/or L-carnitine also can be added, series preparations such as capsules, tablets, powder, granules, oral liquid and medicinal tea can be prepared according to practical requirements, and a more advanced dosage form can be prepared to be used by a consumer by virtue of a newer technology. The composition can be applied to compositions of common food, functional food, health care products and medicines and can be used for slimming and lipid-reducing health care of obese people and prevention and treatment of obesity.

Methods for controlling body weight and/or appetite in a subject are disclosed. In some embodiments, the methods involve administering to an overweight or obese subject an effective amount of a firstagent comprising MIC-1, a MIC- 1 agonist and/or a MIC-1-inducing agent, and a second agent comprising leptin and/or a leptin agonist, for the purpose of achieving weight loss. In other embodiments, the methods involve administering to an anorexic or cachectic subject an effective amount of a MIC-1-inhibiting agent and a leptin-inhibiting agent, for the purpose of increasing body weight and/or appetite in a subject.